9823 Capital »

Neuropace shares owned by 9823 Capital

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by 9823 Capital from 13F filings

Historical chart of 9823 Capital investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by 9823 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by 9823 Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $175k 13k 13.15

More positions owned by 9823 Capital

Apple (AAPL)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
SPDR S&P 500 ETF TR Tr Unit (SPY)
Ishares Tr Ultra Short Dur (ICSH)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
T Rowe Price Etf Ultra Shrt Trm (TBUX)
Microsoft Corporation (MSFT)
Invesco Actively Managed Exc Var Rate Invt (VRIG)
Two Rds Shared Tr Anfield Unvl Etf (AFIF)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Angel Oak Funds Trust Income Etf (CARY)
eBay (EBAY)
Equinix (EQIX)

View all positions for 9823 Capital

Top funds holding Neuropace

Soleus Capital Management
Polar Capital Holdings
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group

View all funds holding Neuropace